Stocks in play: The Yield Growth Corp.

Announced that on November 4, 2019 it entered into a definitive agreement to license 126 formulas based on ancient Ayurvedic medicine to its wholly owned subsidiary Flourish Mushroom Labs for use in products infused with functional or magic mushrooms for a 50 year term. In consideration for the non-exclusive 50 year license, Flourish Mushroom Labs has agreed to pay $3,000,000 to Yield Growth. The fee is payable as follows: $1,800,00 payable as 90 million common shares of Flourish Mushroom Labs to be issued to Yield Growth at a deemed value of $0.02 per share, which shall be subject to escrow provisions pursuant to NP 46-201. The remaining sum of $1,200,000 may be paid in cash over 24 months, but if Flourish Mushroom Labs is successful in listing its stock on a Canadian stock exchange under the symbol "MUSH", which symbol has already been reserved, within 6 months, then $200,000 shall be deducted from the purchase price, and if a listing is achieved between 6 - 12 months, then $400,000 shall be deducted from the purchase price. The Yield Growth Corp. shares BOSS:CNX are trading up 3.51 percent at $0.30.

READ:

• Flourish Mushroom Labs Adds 126 New Formulas to Portfolio, Yield Growth Adds $3 Million to Coffers

• Immunotherapy Drug Pairings Revitalizing the Fight Against Cancer

• 5 Stocks To Watch As Gold Prices Soar